Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-041275
Filing Date
2025-04-29
Accepted
2025-04-29 16:21:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2512589d4_defa14a.htm DEFA14A 12837
2 GRAPHIC tm2512589d4_defa14aimg001.jpg GRAPHIC 162919
3 GRAPHIC tm2512589d4_defa14aimg002.jpg GRAPHIC 56734
  Complete submission text file 0001104659-25-041275.txt   309032
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33277 | Film No.: 25888017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)